Metraipolis › archive › dc_07075fd782de

Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42597438
DOI
10.3389/fnut.2026.1843743
License (as archived)
solo-consultazione
Archived
2026-10-17T07:19:25.056Z
SHA-256 of the archived text
dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f
Stable URL of this page
https://metraipolis.com/documento/dc_07075fd782de

How to cite

Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438 — Europe PMC (en), https://europepmc.org/article/MED/42597438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07075fd782de (Metraipolis archive dc_07075fd782de, sha256 dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f)
BibTeX
@misc{dc07075fd782de,
  title = {Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42597438},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07075fd782de; sha256 dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42597438. Agents can read the archived copy with the MCP tool read_document.